Home / Brands / Amring Pharmaceuticals

Amring Pharmaceuticals Recalls

1 recall on record · June 21, 2023 to June 21, 2023 · Drugs

June 21, 2023DrugsFDA

Amring Pharmaceuticals Inc recalls Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: Amring Pharmaceuticals

Hazard: Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

Amring Pharmaceuticals Recalls | RecallWatchUSA